Healthcare

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on...

CMS Finalizes OPPS Payment for Eko Health’s SENSORA® Platform, Expanding Reimbursement for AI-Enabled Cardiac Disease Detection in Hospital-Associated Outpatient Care

Final rule establishes national reimbursement under OPPS for AI-assisted cardiac analysis, enabling earlier cardiac disease detection in routine outpatient careSAN...

error: Content is protected !!